Clinical Cardiology 1401 - Clinical Cardiology Alert - Jan 01, 2010

Target Audience:

This activity is intended for the cardiologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Michael H. Crawford, MD
Professor of Medicine
Chief of Cardiology
University of California
San Francisco

Editorial Board Members
John P. DiMarco, MD, PhD
Professor of Medicine
Division of Cardiology
University of Virginia
Charlottesville

Jonathan Abrams, MD
Professor of Medicine
Division of Cardiology
University of New Mexico
Albuquerque

Andrew J. Boyle, MBBS, PhD
Assistant Professor of Medicine
Interventional Cardiology
University of California
San Francisco

Peer Reviewer
Ethan Weiss, MD
Assistant Professor of Medicine
Division of Cardiology and CVRI
University of California
San Francisco

Subjects:

  • Clopidogrel for Two Years after Drug-eluting Stents?
  • Left Main Stenting
  • Statins and Bypass Surgery — Is There a Benefit?
  • ACE Inhibitors and CABG Outcomes
  • Bi-ventricular vs. RV Apical Pacing
  • Appropriate Utilization of ICDs

Objectives:

  • to present the latest information regarding diagnosis and treatment of cardiac disease
  • to discuss the pros and cons of these interventions, as well as possible complications
  • to discuss the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • to present current data regarding outpatient care of cardiac patients

Financial Disclosure:

Clinical Cardiology Alert’s physician editor, Michael H. Crawford, MD, is on the speaker’s bureau for Pfizer. Editorial board member Andrew J. Boyle, MBBS, PhD and peer reviewer, Ethan Weiss, MD, reports no consultant, stockholder, speaker’s bureau, or other financial relationship with any company related to this field of study. Editorial board member Jonathan Abrams, MD serves on the speaker's bureau for Merck, Pfizer, and Parke-Davis. Editorial board member John P. DiMarco, MD, PhD is a consultant for Novartis, and does research for Medtronic and Guidant.

Copyright 2010 AHC Media. All rights reserved.